Silver Book Fact

The annual burden to the U.S. economy of age-related macular degeneration (AMD), cataract, diabetic retinopathy, glaucoma, refractive errors, visual impairment, and blindness in adults age 40 and older is estimated at $35.4 billion– $16.2 billion in direct medical costs, $11.1 billion in other direct costs, and $8 billion in lost productivity.

Rein, David B., Ping Zhang, Kathleen E. Wirth, Paul P. Lee, Thomas J. Hoerger, Nancy McCall, Ronald Klein, James M. Tielsch, Sandeep Vijan, and Jinan Saaddine. The Economic Burden of Major Adult Visual Disorders in the United States. Arch Opthalmol. 2006; 124(12): 1754-60. http://archopht.ama-assn.org/cgi/content/abstract/124/12/1754

Reference

Title
The Economic Burden of Major Adult Visual Disorders in the United States
Publication
Arch Opthalmol
Publication Date
2006
Authors
Rein, David B., Ping Zhang, Kathleen E. Wirth, Paul P. Lee, Thomas J. Hoerger, Nancy McCall, Ronald Klein, James M. Tielsch, Sandeep Vijan, and Jinan Saaddine
Volume & Issue
Volume 124, Issue 12
Pages
1754-60
URL
Read Full Resource

Categories

  • Cost of Disease
  • Economic Burden

Related Facts

  • Visual impairment (compared to no visual impairment) is associated with more than $1,000 in excess annual medical expenses per person.  
  • The average cost in 2004 per glaucoma patient age 40 to 64 using outpatient services was $276. The average cost per patient 54 years and older was $254.  
  • Chronic dry eye has a clinically important impact on approximately 4.25 million Americans age 50 and older–3.2 million women and 1.05 million men.  
  • World Blindess from DR
     
  • People Affected Worldwide by DR
    By 2030, more than 191 million people around the world will be affected by DR—56 million with vision-threatening DR.